PET-CT can inform decision to omit bleomycin in Hodgkin lymphoma treatment to reduce toxicity

¹²³I-MIBG- and 18F-FDG-PET-imaging, two nuclear imaging methods for diagnosing neuroblastoma tumours

18F-Choline PET/MRI: The additional value of PET for MRI-guided transrectal prostate biopsies

18F-FDG-PET/CT vs CT in cancer detection

A better way to diagnose and manage neuroendocrine tumors

A better way to image metastatic prostate cancer

A new potential biomarker for cancer imaging

Accuracy of [18F]FDG PET/MRI for the detection of liver metastases

Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: A systematic review and meta-analysis

Adding whole-body PET/MRI improves evaluation of colorectal cancer

Automated fluorine radiolabelling moves closer to the clinic

Baseline PET may aid follicular lymphoma decisions

Best tools for measuring mesothelioma treatment response

Better imaging method for Ewing sarcoma response assessment

Birth of nuclear medicine: December 24, 1936

Bone marrow biopsy does not add value to PET/CT staging of DLBCL

Breakthrough discovery on element transformation could lead to new way for treating cancer with radiation

Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured

Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence

Comprehensive screening fails to increase occult cancer detection after unprovoked VTE